# Pyxis Oncology, Inc.: Form 8-K, filed Aug 13, 2026

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: 8-K
- Filed: 2026-08-13
- Accepted by EDGAR: Aug 13, 2026, 07:42 ET
- Period: 2026-08-13
- Accession: 0001193125-26-347911
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000119312526347911/pyxs-20260813.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000119312526347911/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000119312526347911/pyxs-20260813.htm

Filed Aug 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-347911. Last ingested by Listed: Nov 14, 2026, 20:08 ET. No prices; not investment advice.
